Thought Leader Select announces neurology key opinion leader work for top-20 global pharmaceutical company

New press release out today from the offices of Thought Leader Select!

FOR IMMEDIATE RELEASE

March 9, 2010 (CHAPEL HILL, NC) —Thought Leader Select, a company dedicated to delivering solutions for better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, is proud to announce the commencement of a new project for a top-20 global pharmaceutical company.

Deep profiling has proven to be up to three times more effective than other more traditional methods, such as influence mapping, in matching pharmaceutical companies with the key opinion leaders who exhibit the skills and experiences needed to develop tomorrow’s drug therapies (source: Thought Leader Select internal comparative research).

Upon project delivery, the client company will be able to utilize Thought Leader Select’s customized engagement recommendations, research reporting and a web-based profiling tool to develop world-class clinical investigation teams and high-synergy advisory boards. As the client builds its investigative teams and advisory boards, the skills and experiences of the global KOLs will drive key applications.

In addition to Thought Leader Select’s deep profiling, the firm will provide qualitative research of the key opinion leaders selected by the pharmaceutical company to aid in the development of their neurology product.  This study will assess KOL preferences for treating certain neurological symptoms, in addition to focusing on sources for product information and which conferences they attend to improve their respective practices.

“I’m very proud of my team for landing this project, and I’m also very grateful that we were chosen above worthy competitors to do such important work for an excellent company,” said Paul Meade, president of Thought Leader Select. “We think this is the beginning of a great relationship.”

About Thought Leader Select

Thought Leader Select is a specialty firm focused on providing solutions—research, technology tools and focused advice/consulting—for more effective KOL engagement and deployment. Thought Leader Select’s groundbreaking work bridges the areas of research, communications and technology. With more than 70 years of combined experience working in and with the pharmaceutical industry, Thought Leader Select is addressing needs for better engagement and more sophisticated deployment of KOLs during drug development and the life cycle of the brand.

Media Contact:

Kristen Smithwick

Vice President of Marketing & Planning

252-945-8352

ksmithwick@thoughtleaderselect.com

More Posts

New White Paper on Patient Engagement

Technological and cultural forces are shifting the expectations that patients bring to their healthcare. Armed with the ever-growing availability of information (and misinformation) on the

New White Paper on Building Speakers Bureaus

The pharmaceutical industry has long used speakers bureaus and their associated meetings and events to educate healthcare providers (HCPs) about drug therapies and the diseases those drugs

Share:

Send Us A Message